Home › NDC Lookup › RxCUI directory › RxCUI 577212

Tipranavir 250 MG Oral Capsule — RxCUI 577212

RxNorm drug concept · Semantic clinical drug
RxCUI 577212 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI577212
Official nameTipranavir 250 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tipranavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — tipranavir on its own is broken down so fast by the liver that it never reaches the blood levels needed to fight HIV. Ritonavir acts as a booster: it slows down that breakdown...
  • Why do I have to take this medication with ritonavir? Can't I just take tipranavir alone?
  • It depends on which form of ritonavir you're using. If your ritonavir comes as tablets, then yes — you must take Aptivus with a meal every time. If you're using ritonavir capsules,...
  • Do I need to eat when I take Aptivus capsules?
📖 Read our full Tipranavir guide →

🕸️ Concept Web — How Tipranavir 250 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tipranavir 250 MG Oral Capsule RxCUI 577212

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tipranavir 190548
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Aptivus 614593
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tipranavir Oral Capsule 577211
    • Tipranavir Oral Product 1162110
    • Tipranavir Pill 1162111
    • Tipranavir Oral Capsule [Aptivus] 603377
    • Aptivus Oral Product 1168600
    • Aptivus Pill 1168601
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tipranavir 250 MG SCDC · 577210
  • Tipranavir Oral Capsule SCDF · 577211
  • Tipranavir Oral Product SCDG · 1162110
  • Tipranavir Pill SCDG · 1162111

Brand-Name Concepts

  • Tipranavir 250 MG Oral Capsule [Aptivus] SBD · 603378
  • Tipranavir 250 MG [Aptivus] SBDC · 603376
  • Tipranavir Oral Capsule [Aptivus] SBDF · 603377
  • Aptivus Oral Product SBDG · 1168600
  • Aptivus Pill SBDG · 1168601
  • Aptivus BN · 614593

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 577212 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0003-02 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0597-0003-0... Aptivus Boehringer Ingelheim Pharmaceuticals, Inc. 2005-07-01
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.